800-551-0488

Lab results are too important to go anywhere else

Beaumont Laboratory

Program

7:30 a.m.

Registration and continental breakfast (Foyer)

Association for Molecular Pathology (AMP) Education Series
Program Moderators: Bobby Boyanton, Jr., M.D., Medical Director, Microbiology, and Associate Medical Director, Molecular Pathology, Beaumont Hospital, Royal Oak; and Gabriel Maine, Ph.D., Director, Histocompatibility, Beaumont Hospital, Royal Oak.

8:00 – 8:15 a.m.

Historical Perspective of the DNA Symposium through 25 years
John Gibson, M.S., SV(ASCP), CLSp(MB), CLAS-MDx, Beaumont Hospital, Royal Oak, MI

8:15 – 9:00 a.m.

Liquid Biopsy of Cancer: From Research to Bedside
Jimmy Lin, M.D., Ph.D., Natera, San Carlos, CA

9:00 – 9:45 a.m.

Digital Droplet PCR (ddPCR): Research and Clinical Applications
Sabine Hellwig, Ph.D., ARUP Laboratories, Salt Lake City, UT

9:45 – 10:15 a.m.

Break (in Exhibit Hall)

10:15 - 11:00 a.m.


Genomic (Next-Generation) Sequencing for Diagnosing Constitutional Genetic Diseases – The Bird’s-Eye View
Mark Micale, Ph.D., Beaumont Hospital, Royal Oak, MI

11:15 a.m. - 12:00 p.m.

Corporate Workshop*

12:00 - 1:00 p.m.

Lunch (in Exhibit Hall)

1:00 - 1:45 p.m.

Corporate Workshop*


Hot Topics
Program Moderators: Mark Micale, Ph.D., Director, Cytogenetics, Beaumont Health System; and Gabriel Maine, Ph.D., Director, Histocompatibility, Beaumont Hospital, Royal Oak

2:00 - 2:45 p.m.

*KEYNOTE*
Clinical Applications of CRISPR/Cas9 Gene Editing

Jacob Corn, Ph.D. University of California, Berkeley, CA

2:45 - 3:30 p.m.

Predictive Markers in the Liquid Biopsy
Madhu Kalia, M.D., Ph.D., MBA, Jefferson Medical College, Philadelphia, PA

3:30 - 4:00 p.m.

Break (in Exhibit Hall)

4:00 - 4:45 p.m.

Autism - Neurodevelopmental Disarray
Owen M. Rennert, M.D. Eunice Kennedy Schriver National Institute of Child Health and Human Development (NICHD) NIH

4:45 - 6:00 p.m.

Wine and Cheese Reception

Corporate Exhibits open until 6:00 p.m.

*The corporate workshops are not endorsed by Beaumont Health System and are not part of the CME activity.

7:30 a.m.

Registration and continental breakfast (Foyer)

Molecular Hematology/Oncology
Program Moderators: Mitual Amin, M.D., Interim Chair, Anatomic Pathology, Beaumont Hospital, Royal Oak; and Domnita Crisan, M.D., Ph.D., Director, Molecular Pathology, Beaumont Hospital, Royal Oak

8:00 – 8:45 a.m.


Integrating Clinical NGS Findings in Patient Care Decisions: The Next Frontier in Personalized Cancer Care
Keyur Patel, M.D., Ph.D., MD Anderson Cancer Center, Houston, TX

8:45 – 9:30 a.m.


Molecular Profiling of Myeloid Neoplasms
Mohammad Vasef, M.D., University of New Mexico, Albuquerque, NM

9:30 – 10:00 a.m.

Break (Exhibits Open)

10:00 – 10:45 a.m.


Case Presentations

Mohammad Vasef, M.D., University of New Mexico, Albuquerque, NM

10:45 – 11:00 a.m.

Break

11:00 a.m. - 11:45 p.m.

Corporate Workshop*

12:00 - 1:00 p.m.

Lunch (in Exhibit Hall)

1:00 - 1:45 p.m.

Corporate Workshop*


Molecular Microbiology
Program Moderators: Bobby Boyanton Jr., M.D., Medical Director and Barbara Robinson-Dunn, Ph.D., Technical Director, Microbiology, Beaumont Hospital, Royal Oak.

2:00 - 2:45 p.m.


The Challenges of Laboratory Testing for Zika Virus Infection
Janice Matthews-Greer, Ph.D., D(ABMM), Michigan Department of Health and Human Services, Lansing

2:45 - 3:15 p.m.

Break (in Exhibit Hall)

3:15 - 4:00 p.m.


The Changing Paradigm of the Laboratory Diagnosis of Gastroenteritis
Melissa B. Miller, Ph.D. University of North Carolina School of Medicine, Chapel Hill, NC

4:00 - 4:45 p.m.


The Diagnosis of C. difficile Infections: Does Molecular Make It More or Less "difficile"?
Stephen M. Brecher, Ph.D., VA Boston Healthcare System, Roxbury, MA

4:45 p.m.

Closing remarks


*The corporate workshops are not endorsed by Beaumont Health System and are not part of the CME activity.

Stephen M. Brecher, Ph.D., VA Boston Healthcare System, Roxbury, MA

Jacob Corn, Ph.D., University of California, Berkeley, CA

John Gibson, M.S., SV(ASCP), CLSp(MB), CLAS-MDx, Beaumont Hospital, Royal Oak, MI

Sabine Hellwig, Ph.D., ARUP Laboratories, Salt Lake City, UT

Madhu Kalia, M.D., Ph.D., MBA, Jefferson Medical College, Philadelphia, PA

Jimmy Lin, M.D., Ph.D., Natera, San Carlos, CA

Janice Matthews-Greer, Ph.D., D(ABMM), Michigan Department of Health and Human Services, Lansing

Mark Micale, Ph.D., Beaumont Hospital, Royal Oak, MI

Melissa Miller, PhD, D(ABMM), University of North Caroline School of Medicine, Chapel Hill, North Carolina

Keyur Patel, M.D., Ph.D., MD Anderson Cancer Center, Houston, TX

Owen M. Rennert, M.D., Eunice Kennedy Schriver National Institute of Child Health and Human Development (NICHD) NIH

Mohammad Vasef, M.D., University of New Mexico/TriCore Reference Lab

Department of Clinical Pathology 
Beaumont Health System, Royal Oak, Michigan

Course Directors/OUWB School of Medicine Faculty

Domnita Crisan, M.D., Ph.D., HCLD, Professor
Mitual Amin, M.D., Interim Chair, Professor
Mark Kolins, M.D., FACPE, Emeritus, Professor

Committee Members/OUWB School of Medicine Faculty

Anne Marie Blenc, M.D., Associate Professor
Bobby L. Boyanton, Jr., M.D., FASCP, FCAP, Associate Professor
Vonda Douglas-Nikitin, M.D., Associate Professor
James Huang, M.D., FCAP, Associate Professor
Gabriel Maine, Ph.D., Associate Professor
Mark Micale, Ph.D., FACMG, Associate Professor
Peter A. Millward, M.D., Associate Professor
Barbara Robinson-Dunn, Ph.D., D(ABMM), Professor
John Schwartz, M.D., Assistant Professor
Marc Smith, M.D., Associate Professor
John Gibson, M.S., SV(ASCP), CLSp(MB) 
R. Todd Haight, M.A., Director, Lab Sales and Marketing
Marcy King, B.S., Coordinator
Nancy Ramirez, M.S., MLS(ASCP)SH, Education Manager

Association for Molecular Pathology 
Bethesda, Maryland

Melvin Limson, Ph.D.
Mary Steele Williams, M.N.A., MT(ASCP)SM, C.A.E.